Exelixis, Inc. (EXEL)
43.67
+1.27
(+3.00%)
USD |
NASDAQ |
Jan 06, 16:00
43.67
0.00 (0.00%)
After-Hours: 20:00
Exelixis Price: 43.67 for Jan. 6, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Vanda Pharmaceuticals, Inc. | 8.12 |
| ADMA Biologics, Inc. | 18.33 |
| Aldeyra Therapeutics, Inc. | 4.065 |
| Merck & Co., Inc. | 108.88 |
| Neurocrine Biosciences, Inc. | 137.32 |
Price Related Metrics
| PE Ratio | 18.39 |
| PS Ratio | 5.461 |
| PEG Ratio | 0.3579 |
| Price to Book Value | 5.419 |
| Price to Free Cash Flow | 16.03 |
| Earnings Yield | 5.44% |
| Market Cap | 11.71B |
| PEGY Ratio | 0.3579 |
| Operating PE Ratio | 15.24 |
| Normalized PE Ratio | 18.00 |